Drug intelligence / Profile preview

TBDESJS

Development stage: Preclinical
Lead developer: Taipei Veterans General Hospital
Administration: Oral

Overview

TBDESJS is a Chinese herbal tea formulation developed by researchers at Taipei Veterans General Hospital for the treatment of Sjögren's Syndrome (SJS) and Dry Eye Syndrome (DES). Based on Traditional Chinese Medicine (TCM) principles, the tea is formulated to 'Nourish Yin and Moisten Dryness' to alleviate ocular dryness and systemic symptoms. It is currently being evaluated in clinical trials to assess its efficacy in improving ocular dryness and to explore its immunomodulatory effects through proteomic analysis of plasma exosomes.

Other names: Chinese herbal tea TBDESJS

Beyond the preview

Go deeper on TBDESJS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBDESJS.

Explore the full profile